ResearcherShimane UniversityActive in the last 2 years

Mohammad Mahbubul Hoque

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5039107099. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Senolysis of gemcitabine-induced senescent human pancreatic cancer cells. Co-author DOI 10.1002/cnr2.2075 ↗
Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.15836 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mamoru Harada · 2 shared papers, 2022–2024 · strength 0.51
- Paper Senolysis of gemcitabine-induced senescent human pancreatic cancer cells. DOI 10.1002/cnr2.2075 ↗
- Paper Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer Cells. DOI 10.21873/anticanres.15836 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.